News about Global Pharma

YGION Biomedical Secures EUR 15 Million in Series A Financing for YGNITE

The funds will be used to further develop YGION's innovative YGNITE™ technology platform and advance their lead program, YG-01, into preclinical and clinical stages.

Global Pharma | 21/05/2024 | By Abha |  754

Chroma Medicine Appoints Jenny Marlowe, Ph.D., as Chief Development Officer

Dr. Marlowe joins Chroma from Solid Biosciences (previously AvantiBio), where she was the Chief Scientific Officer, leading discovery, research, and translational development.

Global Pharma | 20/05/2024 | By Manvi |  742

Shoulder Innovations Introduces InSet 95 Humeral Stem

This product is designed to enhance surgical outcomes and improve patient recovery for those suffering from poor bone quality.

Global Pharma | 20/05/2024 | By Manvi |  636

GC Biopharma and Novel Pharma Sanfilippo Syndrome Treatment Receives FDA IND Approval

GC Biopharma and Novel Pharma has announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval.

Global Pharma | 20/05/2024 | By Aishwarya |  900

Cresilon Announces Distribution Agreement for VETIGEL in the UK and Europe

VETIGEL, a plant-based hemostatic gel designed to instantly stop and control bleeding, will be available online through Vi’s extensive range of surgical and orthopedic instruments.

Global Pharma | 20/05/2024 | By Abha |  750

Vector Laboratories and Absolute Biotech Announce Merger to Enhance Life Sciences Offerings

This strategic move aims to solidify Vector Laboratories' position as a comprehensive supplier of custom-engineered and catalog antibodies, sophisticated bioconjugation linkers, and expertise in bioconjugation.

Global Pharma | 20/05/2024 | By Abha |  1216

Jagsonpal Pharmaceuticals to Acquire India and Bhutan Business of Yash Pharma

Jagsonpal Pharmaceuticals Ltd. has signed a Business Transfer Agreement for the acquisition of India and Bhutan business of Yash Pharma for INR 92.47 Crores.

Global Pharma | 20/05/2024 | By Aishwarya |  1665

Meditrina Announces FDA 510(k) Clearance for Gen 2 Bipolar RF Hysteroscopy System and Aveta Glo Bipolar RF Device

This new system features bipolar radiofrequency technology, and a new bipolar RF device called the Aveta Glo, representing a significant advancement in minimally invasive gynecologic procedures.

Global Pharma | 18/05/2024 | By Manvi |  1036

Watkins-Conti Products Gets FDA Approval for Yoni.Fit Bladder Support

Yoni.Fit® is intended for the temporary management of urine leakage caused by stress urinary incontinence (SUI) in women, 18 years and older.

Global Pharma | 18/05/2024 | By Manvi |  470

Glenmark Secures ANDA Approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution

Glenmark Pharmaceuticals Ltd. has received final approval from the United States Food and Drug Administration (US FDA) for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2 percent|0.5 percent.

Global Pharma | 18/05/2024 | By Aishwarya |  480